ClinicalTrials.Veeva

Menu

Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer

N

Nanjing Medical University

Status

Enrolling

Conditions

Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Treatments

Device: Auricular acupuncture treatment
Device: Sham acupuncture group

Study type

Interventional

Funder types

Other

Identifiers

NCT07092111
ACAA 01

Details and patient eligibility

About

Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Full description

This is a Phase II Randomised Controlled Clinical Trial to evaluate the efficacy of auricular acupuncture therapy via the Seirin Pyonex Needles in the prevention of chemotherapy-induced peripheral neuropathy in breast cancer.

Enrollment

110 estimated patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with breast cancer diagnosed with stage I-III;
  • Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
  • 18 years old≤ age≤ 75 years old, female;
  • Subjects voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

  • Patients who have had acupuncture treatment in the past;
  • After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
  • Platelets< 50,000/μL;
  • Patients with CIPN≥1 grade 1 (NCI-CTCAE);
  • Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

110 participants in 2 patient groups

Auricular acupuncture treatment group
Experimental group
Description:
On the basis of conventional nursing, patients are treated with bilateral auricular acupuncture points (Seirin Pyonex Needles φ 0.2 mm × 1.2 mm) before chemotherapy. Specific operation: 1 treatment before each chemotherapy treatment, and 2 treatments a week in the 2nd and 3rd weeks of the chemotherapy interval. The patient was instructed to press the acupuncture point for 3 times/d, the pressure time was 5min, and the local swelling pain was tolerated by the patient. The doctor took the needle out for the patient after leaving it for 3 days. Treatment was continued for 4 cycles of chemotherapy, followed up for 2 months after treatment completion, and routine care was carried out during treatment.
Treatment:
Device: Auricular acupuncture treatment
Sham acupuncture group
Sham Comparator group
Description:
The treatment regimen is the same as that of the auricular acupuncture treatment group, but with a sham acupuncture (Seirin Pyonex Needles).
Treatment:
Device: Sham acupuncture group

Trial contacts and locations

1

Loading...

Central trial contact

Wei Li, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems